Skip to main content
ELAB
NASDAQ Life Sciences

PMGC Holdings Completes $4.8M Acquisition of A&B Aerospace, Expanding into Precision Manufacturing

Analysis by Arik Shkolnikov
Sentiment info
Positive
Importance info
9
Price
$1.98
Mkt Cap
$8.412M
52W Low
$1.62
52W High
$309.12
Market data snapshot near publication time

summarizeSummary

PMGC Holdings Inc. has completed the acquisition of A&B Aerospace, Inc. for $4.8 million, significantly expanding its presence in precision aerospace and defense manufacturing as part of its roll-up strategy.


check_boxKey Events

  • Acquisition Completed

    PMGC Holdings Inc. completed the acquisition of 100% of A&B Aerospace, Inc. on May 12, 2026.

  • Purchase Consideration

    The total consideration for the acquisition was $4.8 million in cash, including a $225,000 indemnification holdback.

  • Strategic Expansion

    This acquisition expands PMGC's presence in precision CNC machining for the aerospace and defense markets, aligning with its roll-up strategy.

  • Target Financials

    A&B Aerospace reported approximately $5.0 million in revenue and $610,000 in management-adjusted EBITDA for the trailing twelve months ended February 28, 2026.


auto_awesomeAnalysis

This acquisition is highly significant for PMGC Holdings, representing approximately 57% of its current market capitalization. It marks a substantial expansion into the precision aerospace and defense manufacturing sector, aligning with the company's stated roll-up strategy. For a company that recently received a going concern warning and has been actively raising capital through dilutive equity lines, successfully acquiring a profitable entity like A&B Aerospace (which reported $5.0M in revenue and $610K management-adjusted EBITDA) is a critical step towards building a sustainable business and addressing its financial challenges. The strategic fit with established blue-chip customers and high technical barriers to entry is a strong positive.

At the time of this filing, ELAB was trading at $1.98 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.4M. The 52-week trading range was $1.62 to $309.12. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed ELAB - Latest Insights

ELAB
May 13, 2026, 6:05 AM EDT
Filing Type: 8-K
Importance Score:
9
ELAB
May 13, 2026, 4:03 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
ELAB
May 04, 2026, 5:14 PM EDT
Filing Type: PRE 14A
Importance Score:
8
ELAB
Apr 28, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
7
ELAB
Apr 27, 2026, 4:01 PM EDT
Filing Type: DEF 14C
Importance Score:
9
ELAB
Apr 24, 2026, 9:18 AM EDT
Filing Type: PRE 14C
Importance Score:
9
ELAB
Apr 23, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
7
ELAB
Apr 21, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
8
ELAB
Apr 20, 2026, 4:37 PM EDT
Filing Type: 424B5
Importance Score:
9
ELAB
Apr 17, 2026, 7:32 AM EDT
Filing Type: PRE 14C
Importance Score:
9